Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazepam in Clinical High Risk of Psychosis
NCT06190483Completed
- Sponsor
- King's College London
- Start
- Jul 2019
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of diazepam in schizophrenia, sponsored by King's College London. Primary endpoint: GABA/Glutamate concentrations at 6 weeks. Started Jul 2019; status: completed.
02
Drugs
diazepam
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT06190483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06190483.